Fatal case of Israeli spotted fever after Mediterranean cruise

Emerging Infectious Diseases

Volumn 14, Issue 12, 2008, Pages 1944-1946

  Boillat, Noémie ^a   Genton, Blaise ^a   D'Acremont, Valérie ^a   Raoult, Didier ^b   Greub, Gilbert ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CLARITHROMYCIN; DOXYCYCLINE; HYPERTENSIVE FACTOR; IMIPENEM; OUTER MEMBRANE PROTEIN A;

ADULT; ANTIBIOTIC THERAPY; AUTOPSY; BACTERIAL GENE; BACTERIAL STRAIN; BOUTONNEUSE FEVER; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATALITY; FEVER; GENE SEQUENCE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; HUMAN TISSUE; HYPOTENSION; INTENSIVE CARE UNIT; ISRAELI SPOTTED FEVER; KIDNEY DYSFUNCTION; LABORATORY TEST; LETTER; LIBYAN ARAB JAMAHIRIYA; MALE; MEDITERRANEAN SEA; METABOLIC ACIDOSIS; NUCLEOTIDE SEQUENCE; RASH; RICKETTSIA CONORII; SEQUENCE ANALYSIS; SKIN BIOPSY; STRAIN DIFFERENCE; TRAVEL;

BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BIOPSY; BOUTONNEUSE FEVER; FATAL OUTCOME; HUMANS; MALE; MEDITERRANEAN SEA; MIDDLE AGED; RICKETTSIA CONORII; SEQUENCE ANALYSIS, DNA; SKIN; TRAVEL;

EID: 57049127131     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1412.070641     Document Type: Letter

References (10)

1. Zhu Y, Fournier PE, Eremeeva M, Raoult D. Proposal to create subspecies of Rickettsia conorii based on multi-locus sequence typing and an emended description of Rickettsia conorii. BMC Microbiol. 2005;5:11.
2. Fournier PE, Dumler JS, Greub G, Zhang J, Wu Y, Raoult D. Gene sequence-based criteria for identification of new Rickettsia isolates and description of Rickettsia heilongjiangensis sp. nov. J Clin Microbiol. 2003;41:5456-65.
3. Giammanco GM, Mansueto S, Ammatuna P, Vitale G. Israeli spotted fever Rickettsia in Sicilian Rhipicephalus sanguineus ticks. Emerg Infect Dis. 2003;9:892-3.
4. Gross EM, Yagupsky P. Israeli spotted fever in children. A review of 54 cases. Acta Trop. 1987;44:91-6.
5. Wolach B, Franco S, Bogger-Goren S, Drucker M, Goldwasser RA, Sadan N, et al. Clinical and laboratory findings of spotted fever in Israeli children. Pediatr Infect Dis. 1989;8:152-5.
6. Bacellar F, Beati L, França A, Poças J, Regnery R, Filipe A. Israeli spotted fever rickettsia (Rickettsia conorii complex) associated with human disease in Portugal. Emerg Infect Dis. 1999;5:835-6.
7. Giammanco GM, Vitale G, Mansueto S, Capra G, Caleca MP, Ammatuna P. Presence of Rickettsia conorii subsp. israelensis, the causative agent of Israeli spotted fever, in Sicily, Italy, ascertained in a retrospective study. J Clin Microbiol. 2005;43:6027-31.
8. De Sousa R, Ismail N, Doria-Nobrega S, Costa P, Abreu T, França A, et al. The presence of eschars, but not greater severity, in Portuguese patients infected with Israeli spotted fever. Ann N Y Acad Sci. 2005;1063:197-202.
9. Yagupsky P, Wolach B. Fatal Israeli spotted fever in children. Clin Infect Dis. 1993;17:850-3.
10. Fournier PE, Raoult D. Suicide PCR on skin biopsy specimens for diagnosis of rickettsioses. J Clin Microbiol. 2004;42:3428-34.